| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg | |||
| Other Sizes |
| Targets |
GPR120 modulator 1 targets GPR120 (FFAR4), a receptor for long-chain fatty acids. By modulating this receptor, the compound is useful for researching diseases associated with its abnormal regulation, such as diabetes. It serves as a tool compound to study the structure-activity relationship of GPR120 and its ligands.
|
|---|---|
| ln Vitro |
In vitro studies demonstrate that GPR120 modulator 1 is useful for modulating GPR120 activity. It is used as a tool compound to study the structure-activity relationship of GPR120 and its ligands. Its activity is typically assessed in cell-based assays measuring downstream signaling.
|
| ln Vivo |
In vivo, GPR120 modulator 1 is used to research diseases associated with abnormal GPR120, such as diabetes. By modulating the receptor, it can help elucidate the role of GPR120 in metabolic pathways and its potential as a therapeutic target.
|
| Enzyme Assay |
In vitro receptor binding assays for GPR120 modulator 1 are performed to measure its affinity for GPR120. These assays typically involve competitive displacement of a labeled ligand from the receptor using membranes from cells expressing human GPR120. Its modulatory activity is confirmed in functional assays measuring downstream signaling pathways.
|
| Cell Assay |
Cellular assays for GPR120 modulator 1 are conducted using cell lines expressing GPR120 to evaluate its effects on receptor signaling. Cells are treated with the compound, and downstream signaling events are measured to determine its modulatory activity and potency.
|
| Animal Protocol |
In vivo animal studies for GPR120 modulator 1 are conducted in models of metabolic disorders such as diabetes. Animals are treated with the compound, and endpoints such as glucose tolerance and insulin sensitivity are assessed to evaluate its potential.
|
| ADME/Pharmacokinetics |
The pharmacokinetic properties of GPR120 modulator 1 are characteristic of a small molecule. It has a molecular weight of 389.85 and a molecular formula of C19H16ClNO4S. It is soluble in DMSO and is typically stored at -20degC. It can be formulated for in vivo administration.
|
| Toxicity/Toxicokinetics |
The toxicological profile of GPR120 modulator 1 is not fully detailed. As a research compound, its safety is primarily evaluated in preclinical studies. It is for research use only and is not for human therapeutic use. Standard safety precautions should be followed.
|
| References | |
| Additional Infomation |
GPR120 modulator 1 is a tool compound for studying GPR120 (FFAR4). It is used in research on diseases associated with abnormal GPR120, such as diabetes. It is available for research use only and is not for therapeutic use.
|
| Molecular Formula |
C19H16NO4SCL
|
|---|---|
| Molecular Weight |
389.85264
|
| Exact Mass |
389.049
|
| CAS # |
1050506-75-6
|
| PubChem CID |
25017320
|
| Appearance |
White to off-white solid powder
|
| LogP |
4.814
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
7
|
| Heavy Atom Count |
26
|
| Complexity |
469
|
| Defined Atom Stereocenter Count |
0
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ≥ 100 mg/mL (~256.51 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.41 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.41 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5651 mL | 12.8254 mL | 25.6509 mL | |
| 5 mM | 0.5130 mL | 2.5651 mL | 5.1302 mL | |
| 10 mM | 0.2565 mL | 1.2825 mL | 2.5651 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
